Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Study
2023-06-08 15:04:22
Artistic rendition of diabetic eye disease highlighting vascular changes (i.e., retinal neovascularization) observed in patients with proliferative diabetic retinopathy. Credit: Isabella S. Sodhi, McDonogh School
News from our full member the Wilmer Eye Institute – Johns Hopkins
Research from Akrit Sodhi and colleagues shows that an experimental drug may prevent or slow vision loss in people with diabetes.
More information here!
Source and image: Wilmer Eye Institute – Johns Hopkins
More news
Celebrating LVPEI at ARVO 2025
One of the world’s premier eye research conferences, the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), concluded this month at Salt Lake City, USA. At a glittering […]
These contact lenses give people infrared vision — even with their eyes shut
Sci-fi-style technology uses nanoparticles to convert infrared light into visible light that humans can see. Humans have a new way of seeing infrared light, without the need for clunky night-vision […]
Call for Abstracts – deadline coming up
The 19th Annual Meeting of the WAEH is approaching! You do not want to miss this exciting meeting! We will be talking about: Meet & network with our global […]
Management Training and Systems Development for Eye Hospital Administrators/Managers
7th Aug – 5th Sep, 2025
LAICO, Madurai.
WAEH April Newsletter
WAEH Webinar How to set up an Internet Hospital? Learnings from EYE & ENT Hospital of Fudan University, Shanghai, China! Register now for the WAEH Webinar about the Internet Hospital […]